Search Results 461-470 of 16735 for CLL

1. Publications - Christian L. Baum, M.D. - Mayo Clinic

   Clinical and genetic factors associated with cutaneous squamous cell carcinoma (SCC) among chronic lymphocytic leukemia (CLL) patients Journal of the American ...

2. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

3. Publications - Taimur Sher, M.D. - Mayo Clinic

   Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses. Blood Adv. 2020 May 26; 4 (10):2143 ...

4. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

5. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

6. CAR-T cell therapy - Care at Mayo Clinic

   Chronic lymphocytic leukemia · Diffuse large B-cell lymphoma · Follicular lymphoma · Mantle cell lymphoma · Multiple myeloma. Show more related content. News ...

7. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

   Pathologic diagnosis per local institutional review of Richter syndrome that transformed from chronic lymphocytic leukemia (CLL). Relapsed or refractory ...

8. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

9. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   ... chronic lymphocytic leukemia (CLL) are not eligible; PHASE II: Histological confirmation of transformation of FL lymphoma to diffuse large B cell lymphoma or ...

10. Publications - Fiona E. Craig, M.D. - Mayo Clinic

    Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 ...